Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators to treat an increasingly common liver disease, MASH.

A draft of RFK Jr.'s much-awaited strategy for a healthier America softens rhetoric on agricultural chemicals and stresses ...

Last November, in the days following Donald Trump’s election, leaders at the National Institutes of Health began discussing ...

With U.S. funding for science at risk, a longtime advocate sees ‘light at the end of the tunnel’ in Washington.

When U.S. regulators aren’t in the room while global standards are written, the future of patient safety, medical innovation, ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

In RFK Jr.’s America, it will never be safe to practice public health or medicine," write an epidemiologist and a former CDC ...

Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...

A recent U.S. warning on use of 'march-in' rights against Harvard University seems like distant threat for pharma. Here's why ...

A record-low number of Americans are drinking, according to a new Gallup poll that has been tracking this data since 1939.

Inner speech — the internal monologue in your brain as you think about what to say — can be decoded by computers and might ...

Keeping blood pressure below 120/80 lowers risk of dementia, as well as heart and kidney disease, new guidelines say.